Completed PHASE4 INTERVENTIONAL 3-arm NCT00906828

Pharmacokinetics of Levodopa/Carbidopa Infusion With and Without Oral Catechol-O-methyl Transferase (COMT) Inhibitors (DuoCOMT)

Pharmacokinetics of Levodopa in Patients With Parkinson's Disease Treated With Levodopa/Carbidopa Infusion With and Without Oral COMT Inhibitors

Sponsor: Swedish Parkinson's Disease Foundation

Conditions Parkinson Disease

Interventions entacapone levodopa/carbidopa tolcapone

Updated 5 times since 2017 Last updated: Jan 15, 2010 Started: Oct 31, 2008 Primary completion: Nov 30, 2009 Completion: Nov 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Parkinson Disease and is currently completed. Swedish Parkinson's Disease Foundation leads this study, which shows 5 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Oct 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Swedish Parkinson's Disease Foundation
Swedish Society for Medical Research
Uppsala University

Data source: Uppsala University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Uppsala, Sweden